Cargando…
Delayed and repeated intranasal delivery of bone marrow stromal cells increases regeneration and functional recovery after ischemic stroke in mice
BACKGROUND: Stroke is a leading cause of death and disability worldwide, yet there are limited treatments available. Intranasal administration is a novel non-invasive strategy to deliver cell therapy into the brain. Cells delivered via the intranasal route can migrate from the nasal mucosa to the is...
Autores principales: | Chau, Monica J., Deveau, Todd C., Gu, Xiaohuan, Kim, Yo Sup, Xu, Yun, Yu, Shan Ping, Wei, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5897929/ https://www.ncbi.nlm.nih.gov/pubmed/29649974 http://dx.doi.org/10.1186/s12868-018-0418-z |
Ejemplares similares
-
Transplantation of iPS cell-derived neural progenitors overexpressing SDF-1α increases regeneration and functional recovery after ischemic stroke
por: Chau, Monica, et al.
Publicado: (2017) -
Intranasal Delivery of Apelin-13 Is Neuroprotective and Promotes Angiogenesis After Ischemic Stroke in Mice
por: Chen, Dongdong, et al.
Publicado: (2015) -
Intranasal Delivery of Mesenchymal Stromal Cells Protects against Neonatal Hypoxic–Ischemic Brain Injury
por: McDonald, Courtney A., et al.
Publicado: (2019) -
Intranasal Delivery of Bone Marrow Stromal Cells Preconditioned with Fasudil to Treat a Mouse Model of Parkinson’s Disease
por: Tang, Yilin, et al.
Publicado: (2020) -
Post-stroke Intranasal (+)-Naloxone Delivery Reduces Microglial Activation and Improves Behavioral Recovery from Ischemic Injury
por: Anttila, Jenni E., et al.
Publicado: (2018)